2 P(harmD)'s in a Pod

Drs. Riley and Vickery continue their discussion on mental health. Dr. Vickery discusses a recent study reporting newly diagnosed mental illnesses secondary to COVID-19 hospitalization. The discussion then moves to the effects of isolation and the lack of community involvement. Finally, the two discuss self-harm, which leads to a discussion about addiction.

Dr. P. Brittany Vickery, a Board Certified Psychiatric Pharmacist, joins Dr. Riley to discuss Mental Health. The conversation begins with a discussion of mental health crises during a pandemic and progresses to a discussion of common struggles and triggers. Drs. Riley and Vickery then discuss the stigma associated with mental health as well as therapy options. Whole person care is the focus, as diet, exercise, wellness, and counseling are presented as therapeutic options.

In the final installment of COVID-19 conversation, Drs. Riley and Vickery discuss vaccine hesitancy. The conversation begins with Dr. Riley laying the ground work for including patients in their medical choices. The conversation then progresses to a discussion of populations in which hesitancy can be understood from a scientific perspective, which may influence one's thoughts on universal mandates. The episode ends with a summary of what Dr. Vickery believes are the key take-home points. Of note, this episode was recorded before the FDA approval of Pfizer's COVID-19 vaccine.

This episode is a continuation of the previous conversation between Dr. Riley and Dr. Vickery concerning the SARS-CoV-2 vaccinations currently available and in development. The discussion encompasses adverse effect comparative statistics (introduced in EP3), and ultimately the mechanism by which the vaccines produce immunogenicity.

Drs. Riley and Vickery continue their conversation on the COVID-19 pandemic. This time, the conversation is centered on the repurposing of older medications as well as the process of vaccine development.

Drs. Riley and Vickery continue their discussion of the COVID-19 pandemic. The conversation begins with a recap of risk factors for severe disease and progresses into an intriguing discussion on disease progression and approaches to therapeutics.

Dr. Treavor Riley sits down with Dr. Stephen Vickery to discuss the COVID-19, Coronavirus pandemic.